Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2415
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy ; volume:21 ; number:1 ; day:31 ; month:5 ; year:2021 ; pages:1-8 ; date:12.2021
BMC ophthalmology ; 21, Heft 1 (31.5.2021), 1-8, 12.2021

Creator
Kumashiro, Shun
Takagi, Seiji
Itokawa, Takashi
Tajima, Akiko
Kobayashi, Tatsuhiko
Hori, Yuichi
Contributor
SpringerLink (Online service)

DOI
10.1186/s12886-021-01980-w
URN
urn:nbn:de:101:1-2021092518481263106930
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kumashiro, Shun
  • Takagi, Seiji
  • Itokawa, Takashi
  • Tajima, Akiko
  • Kobayashi, Tatsuhiko
  • Hori, Yuichi
  • SpringerLink (Online service)

Other Objects (12)

Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy

Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy

Choroidal thickness in older patients with central serous chorioretinopathy

Choroidal thickness in older patients with central serous chorioretinopathy

Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking

Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking

Choroidal Vascularity Index versus Choroidal Thickness as Biomarkers of Acute Central Serous Chorioretinopathy

Choroidal Vascularity Index versus Choroidal Thickness as Biomarkers of Acute Central Serous Chorioretinopathy

Retinal and choroidal changes in steroid-associated central serous chorioretinopathy

Retinal and choroidal changes in steroid-associated central serous chorioretinopathy

Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report

Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report

Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy

Real world outcomes of photodynamic therapy for chronic central serous chorioretinopathy

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

Risk Factors and Outcomes of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy

Risk Factors and Outcomes of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy

Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy

Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy

Related objects